Legal & General Group’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Legal & General Group’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-4,533	Closed	-$340K	–	2841
2015 Q3	$340K	Buy	4,533 +1,071	+31%	+$80K	﹤0.01%	1428
2015 Q2	$260K	Buy	3,462 +850	+33%	+$45.5K	﹤0.01%	1614
2015 Q1	$130K	Hold	2,612	–	–	﹤0.01%	1877
2014 Q4	$93K	Hold	2,612	–	–	﹤0.01%	2030
2014 Q3	$87K	Buy	+2,612	New	+$92K	﹤0.01%	1989

Legal & General Group's KYTH Position: Q4 2015 in Review

Legal & General Group sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 4,533 shares — an estimated $340K sold.

Legal & General Group first reported a position in KYTH in Q3 2014 and held it in 5 quarters. The position peaked at $340K in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

Legal & General Group reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
Legal & General Group sold 4,533 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $340K.
Legal & General Group first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q3 2014 and held it in 5 quarters.
Legal & General Group's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $340K in Q3 2015.
0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Legal & General Group's 13F filing for Q4 2015, filed 16 Feb 2016.